Loading…
MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Expression of Concern]
Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175.
Saved in:
Published in: | Cancer management and research 2022-01, Vol.14, p.387-388 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 388 |
container_issue | |
container_start_page | 387 |
container_title | Cancer management and research |
container_volume | 14 |
creator | Zheng, Rui-Peng Ma, Dong-Kai Li, Zhuo Zhang, Hai-Feng |
description | Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175. |
doi_str_mv | 10.2147/CMAR.S359215 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0213780d97c74d63b26cedc41eda78e8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A693388377</galeid><doaj_id>oai_doaj_org_article_0213780d97c74d63b26cedc41eda78e8</doaj_id><sourcerecordid>A693388377</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-e49423d98e21f9a57d5ffa0a01fff75604a33cf85c0edf2ea17e2e75de6a42833</originalsourceid><addsrcrecordid>eNptUk1v1DAUjBCIlsKNM7LEhQNZ_JXYuSCtopZW2gppWU4IWV7nOeslibd2gujP4B_jZZfSIuSDrffmzeiNJ8teEjyjhIt39fV8OfvEioqS4lF2SoiocsIofXzvfZI9i3GLcVkRxp9mJ6wgpJBMnmY_r90yJ7xAS2inTo8Q0bgBVG-g9wGii6MeDCBv0SXs9OgMqnUwbvC9RjV0XUTzVrshjqjIL7rJBz8FbVyH1rdopUMLoxtatPJdly_cN0gyBnajD4ijL-c_dkkiOj_s-WufhMLw9Xn2xOouwovjfZZ9vjhf1Zf54uOHq3q-yA1ndMyBV5yyppJAia10IZrCWo01JtZaUZSYa8aMlYXB0FgKmgigIIoGSs2pZOwsuzrwNl5v1S64Xodb5bVTvws-tEqHtHAHClPChMRNJYzgTcnWtDTQGE6g0UKCTFzvD1y7ad2nDgxj0N0D0oedwW1U678rKbHguEwEb44Ewd9MEEfVu2iSv3oAP0VFS1pinP6YJ-jrf6Db5PmQrNqjKi4ZF9VfVKvTAm6wPumaPamalxVjUjIhEmr2H1Q6DfTO-AGsS_UHA28PAyb4GAPYux0JVvs4qn0c1TGOCf7qvi934D_5Y78AocvaTQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2629483479</pqid></control><display><type>article</type><title>MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Expression of Concern]</title><source>PubMed Central (Open Access)</source><source>Taylor & Francis</source><source>Publicly Available Content Database</source><creator>Zheng, Rui-Peng ; Ma, Dong-Kai ; Li, Zhuo ; Zhang, Hai-Feng</creator><creatorcontrib>Zheng, Rui-Peng ; Ma, Dong-Kai ; Li, Zhuo ; Zhang, Hai-Feng</creatorcontrib><description>Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175.</description><identifier>ISSN: 1179-1322</identifier><identifier>EISSN: 1179-1322</identifier><identifier>DOI: 10.2147/CMAR.S359215</identifier><identifier>PMID: 35115838</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>5- fluorouracil ; Cancer ; Care and treatment ; drug resistance ; Expression of Concern ; Fluorouracil ; hepatic carcinoma ; Liver cancer ; mir-145 ; toll-like receptor 4 (tlr4)</subject><ispartof>Cancer management and research, 2022-01, Vol.14, p.387-388</ispartof><rights>COPYRIGHT 2022 Dove Medical Press Limited</rights><rights>2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Dove Medical Press. 2022 Dove Medical Press.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2629483479/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2629483479?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,25736,27907,27908,36995,36996,44573,53774,53776,74877</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35115838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Rui-Peng</creatorcontrib><creatorcontrib>Ma, Dong-Kai</creatorcontrib><creatorcontrib>Li, Zhuo</creatorcontrib><creatorcontrib>Zhang, Hai-Feng</creatorcontrib><title>MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Expression of Concern]</title><title>Cancer management and research</title><addtitle>Cancer Manag Res</addtitle><description>Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175.</description><subject>5- fluorouracil</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>drug resistance</subject><subject>Expression of Concern</subject><subject>Fluorouracil</subject><subject>hepatic carcinoma</subject><subject>Liver cancer</subject><subject>mir-145</subject><subject>toll-like receptor 4 (tlr4)</subject><issn>1179-1322</issn><issn>1179-1322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1v1DAUjBCIlsKNM7LEhQNZ_JXYuSCtopZW2gppWU4IWV7nOeslibd2gujP4B_jZZfSIuSDrffmzeiNJ8teEjyjhIt39fV8OfvEioqS4lF2SoiocsIofXzvfZI9i3GLcVkRxp9mJ6wgpJBMnmY_r90yJ7xAS2inTo8Q0bgBVG-g9wGii6MeDCBv0SXs9OgMqnUwbvC9RjV0XUTzVrshjqjIL7rJBz8FbVyH1rdopUMLoxtatPJdly_cN0gyBnajD4ijL-c_dkkiOj_s-WufhMLw9Xn2xOouwovjfZZ9vjhf1Zf54uOHq3q-yA1ndMyBV5yyppJAia10IZrCWo01JtZaUZSYa8aMlYXB0FgKmgigIIoGSs2pZOwsuzrwNl5v1S64Xodb5bVTvws-tEqHtHAHClPChMRNJYzgTcnWtDTQGE6g0UKCTFzvD1y7ad2nDgxj0N0D0oedwW1U678rKbHguEwEb44Ewd9MEEfVu2iSv3oAP0VFS1pinP6YJ-jrf6Db5PmQrNqjKi4ZF9VfVKvTAm6wPumaPamalxVjUjIhEmr2H1Q6DfTO-AGsS_UHA28PAyb4GAPYux0JVvs4qn0c1TGOCf7qvi934D_5Y78AocvaTQ</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Zheng, Rui-Peng</creator><creator>Ma, Dong-Kai</creator><creator>Li, Zhuo</creator><creator>Zhang, Hai-Feng</creator><general>Dove Medical Press Limited</general><general>Taylor & Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220101</creationdate><title>MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Expression of Concern]</title><author>Zheng, Rui-Peng ; Ma, Dong-Kai ; Li, Zhuo ; Zhang, Hai-Feng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-e49423d98e21f9a57d5ffa0a01fff75604a33cf85c0edf2ea17e2e75de6a42833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>5- fluorouracil</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>drug resistance</topic><topic>Expression of Concern</topic><topic>Fluorouracil</topic><topic>hepatic carcinoma</topic><topic>Liver cancer</topic><topic>mir-145</topic><topic>toll-like receptor 4 (tlr4)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Rui-Peng</creatorcontrib><creatorcontrib>Ma, Dong-Kai</creatorcontrib><creatorcontrib>Li, Zhuo</creatorcontrib><creatorcontrib>Zhang, Hai-Feng</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer management and research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Rui-Peng</au><au>Ma, Dong-Kai</au><au>Li, Zhuo</au><au>Zhang, Hai-Feng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Expression of Concern]</atitle><jtitle>Cancer management and research</jtitle><addtitle>Cancer Manag Res</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>14</volume><spage>387</spage><epage>388</epage><pages>387-388</pages><issn>1179-1322</issn><eissn>1179-1322</eissn><abstract>Zheng RP, Ma DK, Li Z, Zhang HF. Cancer Manag Res. 2020;12:6165–6175.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>35115838</pmid><doi>10.2147/CMAR.S359215</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1179-1322 |
ispartof | Cancer management and research, 2022-01, Vol.14, p.387-388 |
issn | 1179-1322 1179-1322 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_0213780d97c74d63b26cedc41eda78e8 |
source | PubMed Central (Open Access); Taylor & Francis; Publicly Available Content Database |
subjects | 5- fluorouracil Cancer Care and treatment drug resistance Expression of Concern Fluorouracil hepatic carcinoma Liver cancer mir-145 toll-like receptor 4 (tlr4) |
title | MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Expression of Concern] |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T10%3A30%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MiR-145%20Regulates%20the%20Chemoresistance%20of%20Hepatic%20Carcinoma%20Cells%20Against%205-Fluorouracil%20by%20Targeting%20Toll-Like%20Receptor%204%20%5BExpression%20of%20Concern%5D&rft.jtitle=Cancer%20management%20and%20research&rft.au=Zheng,%20Rui-Peng&rft.date=2022-01-01&rft.volume=14&rft.spage=387&rft.epage=388&rft.pages=387-388&rft.issn=1179-1322&rft.eissn=1179-1322&rft_id=info:doi/10.2147/CMAR.S359215&rft_dat=%3Cgale_doaj_%3EA693388377%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c432t-e49423d98e21f9a57d5ffa0a01fff75604a33cf85c0edf2ea17e2e75de6a42833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2629483479&rft_id=info:pmid/35115838&rft_galeid=A693388377&rfr_iscdi=true |